Imperial College London

Dr Olivier E. Pardo

Faculty of MedicineDepartment of Surgery & Cancer

Reader in Cancer Cell Signalling
 
 
 
//

Contact

 

+44 (0)20 7594 2814o.pardo Website CV

 
 
//

Location

 

145ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Georgiou:2022:10.1038/s41388-022-02251-8,
author = {Georgiou, M and Ntavelou, P and Stokes, W and Roy, R and Maher, GJ and Stoilova, T and Rakhit, CP and Martins, M and Ajuh, P and Horowitz, N and Berkowitz, RS and Elias, K and Seckl, MJ and Pardo, OE},
doi = {10.1038/s41388-022-02251-8},
journal = {ONCOGENE},
pages = {2540--2554},
title = {ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma},
url = {http://dx.doi.org/10.1038/s41388-022-02251-8},
volume = {41},
year = {2022}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - Georgiou,M
AU - Ntavelou,P
AU - Stokes,W
AU - Roy,R
AU - Maher,GJ
AU - Stoilova,T
AU - Rakhit,CP
AU - Martins,M
AU - Ajuh,P
AU - Horowitz,N
AU - Berkowitz,RS
AU - Elias,K
AU - Seckl,MJ
AU - Pardo,OE
DO - 10.1038/s41388-022-02251-8
EP - 2554
PY - 2022///
SN - 0950-9232
SP - 2540
TI - ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma
T2 - ONCOGENE
UR - http://dx.doi.org/10.1038/s41388-022-02251-8
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000770216400001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL - 41
ER -